Biotech

All Articles

Innovent links cytokine to colon cancer cells responses

.Innovent Biologics has actually produced the instance that its checkpoint inhibitor-cytokine combin...

Merck, Daiichi ADC hits target in phase 3 lung cancer cells study

.A phase 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina strengthens AI concentrate along with collab to choose cancer cells aim ats

.Five months after Rakovina Therapies pivoted toward expert system, the cancer-focused biotech has j...

Ascendis' dwarfism medication hits in phase 3, endangers BioMarin

.Ascendis Pharma has emerged as a potential hazard to BioMarin's Voxzogo, reporting period 3 growth ...

Despite ph. 3 overlook, Alkeus views path ahead of time for eye disease property

.Though Alkeus Pharmaceuticals' dental eye disease resource fell short to considerably decrease geog...

Kairos goes social with $6M IPO to money trials of cancer cells medicine

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was effortless to miss a smaller-sc...

Vaccine as well as Keytruda combination helpful in squamous tissue carcinoma

.Invulnerable checkpoint inhibitors are actually the superheroes of cancer cells treatment. Medicati...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, shootings ...

Regeneron's Opdualag opponent presents 57% action fee

.Regeneron is back along with lasting consequence for its LAG-3 prevention and also PD-1 inhibitor c...

AstraZeneca posts information on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has discussed a very early take a look at the functionality of its own in-house antibod...